07 Mar Here’s Why Pfizer PFE is a Strong Value Stock January 23, 2025

The “RIG” portfolio aims for 50% income from defensive sectors and includes 83 stocks across 11+ sectors, focusing on investment-grade stocks. As of 2022, the company had a robust pipeline of potential treatments, with more than 220 in some stage of clinical trials. Among its leading candidates is a vaccine for RSV, a life-threatening respiratory disease affecting children.

• According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average target price of $32.00.
• It employs roughly 79,000 people and is headquartered in New York state.
• Then the balloon popped and the business contracted, sending investors running for the exits.
• Discover which analysts rank highest on predicting the price target of PFE.
• From this list, we further refined our selection criteria by identifying stocks with a projected upside potential of over 10% based on analyst price targets, as of January 20.
• They set a “neutral” rating and a $30.00 target price for the company.

Large Cap US Pick List – January 2025

With the wheels of growth beginning to turn again, that dividend seems like a safe bet to continue paying and growing. The technique has proven to be very useful for finding positive surprises. SCHD is the core of this dividend portfolio idea, ranking the best of the top 20 holdings. Stocks must have paid dividends for 10 years, have a market cap of $500M+, and an average daily trading volum…

Pfizer Eyes $20 Billion Revenue From Acquisitions Amid Patent Cliff Challenges

In 2024, companies in the broader market that paid dividends returned around 35% of their net income and 45% of their free cash flow to shareholders, as reported by Bloomberg. The average dividend yield for these companies was approximately 2.3%, while the market capitalization-weighted yield stood at about 1.5%. Institutional investors and hedge funds have recently bought and sold shares of the stock. Retirement Wealth Solutions LLC bought a new stake in Pfizer in the fourth quarter worth $26,000. Gladius Capital Management LP raised its position in shares of Pfizer by 102.8% during the 3rd quarter.

Get stock recommendations, portfolio guidance, and more from The Motley Fool’s premium services. The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank. As of Aug. 9, 2021, Pfizer had 5,606,688,356 shares of voting common stock outstanding.

No cost, no obligation to buy anything ever.Past performance is no guarantee of future results.

How Style Scores Work with the Zacks Rank

If you are looking for an AI stock that is more promising than PFE but that trades at less than 5 times its earnings, check out our report about the cheapest AI stock. The key is to identify companies that may be at risk of cutting dividends and to reconsider those that reduced payouts a few months earlier. To forecast potential cuts, Senyek examines companies with high dividend yields, substantial debt, and elevated payout ratios. For potential new dividend payers, Senyek seeks out companies with robust free cash flow yields that are actively repurchasing shares and maintaining manageable debt levels. In view of this, we will take a look at stocks with steady dividends.

This represents a $1.72 dividend on an annualized basis and a yield of 6.59%. Three analysts revised their earnings estimate upwards in the last 60 days for fiscal 2024. The Zacks Consensus Estimate has increased $0.03 to $2.94 per share. If you like to use all three kinds of investing, then the VGM Score is for you.

Utilizing one-week price change and the monthly percentage change in earnings estimates, among other factors, the Momentum Style Score can help determine favorable times to buy high-momentum stocks. While good value is important, growth investors are more focused on a company’s financial strength and health, and its future outlook. The Growth Style Score takes projected and historic earnings, sales, and cash flow into account to uncover stocks that will see long-term, sustainable growth. The company’s revenue and profits ballooned during the pandemic on its COVID-19 vaccine and treatment. Then the balloon popped and the business contracted, sending investors running for the exits. Pfizer has become an interesting case of a well-known stock offering an outsized dividend yield.

On Dec. 11, 2020, the Pfizer-BioNTech vaccine became the first COVID-19 vaccine to receive emergency use authorization (EUA) current consumer price index from the U.S. The vaccine was approved for emergency use for individuals 16 years of age and older. On May 10, 2021, the FDA expanded the EUA for the Pfizer-BioNTech vaccine to include adolescents ages 12–15. Investors are realizing that they no longer can count on lower interest rates and inflation to support higher stock and bond prices. The sale decreases Pfizer’s shareholding in the consumer-healthcare business to 7.3% of its issued share capital, down from 15%.

What To Expect From PFE Stock In 2025?

Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Regarding its product line, the company has at least ten blockbuster drugs producing more than $1 billion in avenue revenue each. The US is its main market and represents roughly 50% of all revenue. China and Japan make up roughly 12% of the business, while the rest come from the “rest of the world”. It employs roughly 79,000 people and is headquartered in New York state. Please bear with us as we address this and restore your personalized lists.

Our experts picked 7 Zacks Rank #1 Strong Buy stocks with the best chance to skyrocket within the next days. Thus, the more stocks you own with a #1 or #2 Rank and Scores of A or B, the better. The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of keep a delicate balance with foreign stocks 265) would place in the bottom 1%.

According to 13 analysts, the average rating for PFE stock is “Buy.” The 12-month stock price forecast is $32.17, which is an increase of 23.30% from gamestop leads meme stocks lower, on track for sharp weekly drop the latest price. The business also recently announced a quarterly dividend, which will be paid on Friday, March 7th. Investors of record on Friday, January 24th will be issued a $0.43 dividend.